These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1751760)

  • 1. Analysis of the fine structure of the antigenic determinants of the transmembrane protein in the HIV coat with chemically modified synthetic peptides.
    Andreev SM; Meshcheryakova DB; Vafina MG; Az'muko AA; Sidorova MV; Khaitov RM
    Biomed Sci; 1991; 2(3):271-8. PubMed ID: 1751760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic properties of phage displayed peptides comprising disulfide-bonded loop of the immunodominant region of HIV-1 gp41.
    Cano A; Viveros M; Acero G; Govezensky T; Munguia ME; Gonzalez E; Soto L; Gevorkian G; Manoutcharian K
    Immunol Lett; 2004 Sep; 95(2):207-12. PubMed ID: 15388262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of a subclass-restricted HIV-1 gp41 epitope by omission peptides.
    Mathiesen T; Chiodi F; Broliden PA; Albert J; Houghten RA; Utter G; Wahren B; Norrby E
    Immunology; 1989 May; 67(1):1-7. PubMed ID: 2472353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection.
    Chiodi F; Mathiesen T; Albert J; Parks E; Norrby E; Wahren B
    J Immunol; 1989 Jun; 142(11):3809-14. PubMed ID: 2497181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemistry of the dominating antigenic region Ala582 to Cys604 in the transmembranous protein of simian and human immunodeficiency virus.
    Norrby E; Parks DE; Utter G; Houghten RA; Lerner RA
    J Immunol; 1989 Dec; 143(11):3602-8. PubMed ID: 2584709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
    Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
    Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.
    McGaughey GB; Citron M; Danzeisen RC; Freidinger RM; Garsky VM; Hurni WM; Joyce JG; Liang X; Miller M; Shiver J; Bogusky MJ
    Biochemistry; 2003 Mar; 42(11):3214-23. PubMed ID: 12641452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
    J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of discontinuous linear determinants in peptides.
    Appel JR; Pinilla C; Niman H; Houghten R
    J Immunol; 1990 Feb; 144(3):976-83. PubMed ID: 1688594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Composition of HIV-1 B-epitopes and heterologous T-cell epitopes. I. Maintenance of antigenic properties of HIV-1 B-epitopes].
    Isaguliants MG; Koshida R; Ruden U; Varen B
    Biokhimiia; 1996 Jul; 61(7):1221-9. PubMed ID: 9035735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.
    Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH
    Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies.
    Huarte N; Lorizate M; Kunert R; Nieva JL
    FEBS Lett; 2008 Nov; 582(27):3798-804. PubMed ID: 18930052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergenic and antigenic determinants of latex allergen Hev b 1: peptide mapping of epitopes recognized by human, murine and rabbit antibodies.
    Chen Z; Van Kampen V; Raulf-Heimsoth M; Baur X
    Clin Exp Allergy; 1996 Apr; 26(4):406-15. PubMed ID: 8732237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
    Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
    Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunogenic CBD1 peptide corresponding to the caveolin-1 binding domain in HIV-1 envelope gp41 has the capacity to penetrate the cell membrane and bind caveolin-1.
    Benferhat R; Sanchez-Martinez S; Nieva JL; Briand JP; Hovanessian AG
    Mol Immunol; 2008 Apr; 45(7):1963-75. PubMed ID: 18054388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monoclonal antibody 98-6 reacts with the fusogenic form of gp41.
    Taniguchi Y; Zolla-Pazner S; Xu Y; Zhang X; Takeda S; Hattori T
    Virology; 2000 Aug; 273(2):333-40. PubMed ID: 10915604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping a conserved conformational epitope from the M protein of group A streptococci.
    Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
    Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
    AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP; Bryson S; Nieva JL; Pai EF
    J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.